Media Summary: For years, peptides were seen as complex — too delicate, too unpredictable, too precise to be scaled. But science evolves. Today ... On November 23, 2017, Marina Richardson, Clinical Research Manager at CADTH, in collaboration with the Canadian Society of ... The ACMA takes a detailed look into the world of

Webinar Biologics Biosimilars - Detailed Analysis & Overview

For years, peptides were seen as complex — too delicate, too unpredictable, too precise to be scaled. But science evolves. Today ... On November 23, 2017, Marina Richardson, Clinical Research Manager at CADTH, in collaboration with the Canadian Society of ... The ACMA takes a detailed look into the world of Regulatory, patient, and provider, United States health care leaders join Professor Angela Thomas, Royal Hospital for Sick Children, Edinburgh, UK, presented at Pharmacology 2016, the British ... If you were recently diagnosed with a chronic disease, or use infusions or injectables to manage your health, you might be familiar ...

Medications provide an important option to help you treat your arthritis – yet understanding the options available and determining ... On May 28th, Dr. McCurdy answered the following questions in a very informative

Photo Gallery

WEBINAR: Biologics & Biosimilars
Webinar: Peptides in Focus: Driving the Future of Biosimilars Excellence
WEBINAR: What Is a Biosimilar? The Current Biologics and Biosimilars Landscape in Canada
CADTH Webinar — Biologics and Biosimilars
Biologics and Biosimilars Interchangeability: A Deep Dive with Industry Experts
Webinar: Streamlining the Regulatory Process to Advance Access to Biosimilars
Biosimilars 101: An Educational Webinar in Biosimilars
Biologics & Biosimilars Webinar w/ Alexandra Charlton
Biologics and Biosimilars: Information for Healthcare Providers
15 years of Biosimilars - Online Webinar
The BPCIA and the Naming of Biosimilars
Professor Angela Thomas: "Regulation of biologics & biosimilars"
Sponsored
Sponsored
View Detailed Profile
WEBINAR: Biologics & Biosimilars

WEBINAR: Biologics & Biosimilars

Don't miss our upcoming

Webinar: Peptides in Focus: Driving the Future of Biosimilars Excellence

Webinar: Peptides in Focus: Driving the Future of Biosimilars Excellence

For years, peptides were seen as complex — too delicate, too unpredictable, too precise to be scaled. But science evolves. Today ...

Sponsored
WEBINAR: What Is a Biosimilar? The Current Biologics and Biosimilars Landscape in Canada

WEBINAR: What Is a Biosimilar? The Current Biologics and Biosimilars Landscape in Canada

Don't miss our upcoming

CADTH Webinar — Biologics and Biosimilars

CADTH Webinar — Biologics and Biosimilars

On November 23, 2017, Marina Richardson, Clinical Research Manager at CADTH, in collaboration with the Canadian Society of ...

Biologics and Biosimilars Interchangeability: A Deep Dive with Industry Experts

Biologics and Biosimilars Interchangeability: A Deep Dive with Industry Experts

The ACMA takes a detailed look into the world of

Sponsored
Webinar: Streamlining the Regulatory Process to Advance Access to Biosimilars

Webinar: Streamlining the Regulatory Process to Advance Access to Biosimilars

This

Biosimilars 101: An Educational Webinar in Biosimilars

Biosimilars 101: An Educational Webinar in Biosimilars

Regulatory, patient, and provider, United States health care leaders join

Biologics & Biosimilars Webinar w/ Alexandra Charlton

Biologics & Biosimilars Webinar w/ Alexandra Charlton

Discussed Topics: -What's a

Biologics and Biosimilars: Information for Healthcare Providers

Biologics and Biosimilars: Information for Healthcare Providers

Learn about

15 years of Biosimilars - Online Webinar

15 years of Biosimilars - Online Webinar

The

The BPCIA and the Naming of Biosimilars

The BPCIA and the Naming of Biosimilars

Review the

Professor Angela Thomas: "Regulation of biologics & biosimilars"

Professor Angela Thomas: "Regulation of biologics & biosimilars"

Professor Angela Thomas, Royal Hospital for Sick Children, Edinburgh, UK, presented at Pharmacology 2016, the British ...

Biologics & Biosimilars: Insights for Patients & Physicians

Biologics & Biosimilars: Insights for Patients & Physicians

National

Future of Biosimilar Medications

Future of Biosimilar Medications

Future of

Biologics, Unbranded Biologics, and Biosimilars - What is the difference?

Biologics, Unbranded Biologics, and Biosimilars - What is the difference?

If you were recently diagnosed with a chronic disease, or use infusions or injectables to manage your health, you might be familiar ...

Arthritis Biologics, Biosimilars, and JAK Inhibitors | Arthritis Talks

Arthritis Biologics, Biosimilars, and JAK Inhibitors | Arthritis Talks

Medications provide an important option to help you treat your arthritis – yet understanding the options available and determining ...

Biosimilars for IBD: Making the Transition Webinar

Biosimilars for IBD: Making the Transition Webinar

On May 28th, Dr. McCurdy answered the following questions in a very informative

Webinar Accelerating Biologics Development to Medicines - Key Drivers of Success

Webinar Accelerating Biologics Development to Medicines - Key Drivers of Success

This

The Basics of Biosimilars

The Basics of Biosimilars

What are

Understanding biosimilars: what IBD patients & caregivers need to know

Understanding biosimilars: what IBD patients & caregivers need to know

Have you heard of